Fig. 01 -

Title Slide

Fig. 02 -

Disclosures

Fig. 03 -

Comorbidities

Fig. 04 -

Comorbidities & Management

Fig. 05 -

Causes of Death

Fig. 06 -

Systemic Effects

Fig. 07 -

Main Comorbidities

Fig. 08 -

Prevalence

Fig. 09 -

Sex and GOLD

Fig. 10 -

Comorbidome

Fig. 11 -

Heart Failure

Fig. 12 -

Biomarkers

Fig. 13 -

Cardiac Troponin

Fig. 14 -

Beta-blockers

Fig. 15 -

Ischaemic Heart Disease

Fig. 16 -

COPD & Death

Fig. 17 -

Impact of COPD

Fig. 18 -

Coronary Artery Bypass

Fig. 19 -

Arrhythmias

Fig. 20 -

Sudden Cardiac Death

Fig. 21 -

Peripheral Vascular Disease

Fig. 22 -

PVD & COPD

Fig. 23 -

Hypertension

Fig. 24 -

Osteoporosis

Fig. 25 -

Prevalence of Osteoporosis

Fig. 26 -

Anxiety and Depression

Fig. 27 -

COPD & Anxiety

Fig. 28 -

COPD & Depression

Fig. 29 -

Lung Cancer

Fig. 30 -

Function & Cancer

Fig. 31 -

Lung Cancer Survival

Fig. 32 -

LDCT

Fig. 33 -

Lung Cancer Screening

Fig. 34 -

MS and Diabetes

Fig. 35 -

COPD & MS

Fig. 36 -

COPD & MS (Cont.)

Fig. 37 -

GERD

Fig. 38 -

Bronchiectasis

Fig. 39 -

COPD & Bronchiectasis

Fig. 40 -

Multimorbidity

Fig. 41 -

Multimorbidity in Scotland

Fig. 42 -

Scotland (Continued)

Fig. 43 -

Prevalent Multi-morbidity

Fig. 44 -

5 Years

Fig. 45 -

Hospitalisation

Fig. 46 -

No Evidence & Simplicity

Fig. 47 -

Guidelines & Multimorbidity

Fig. 48 -

Exacerbations

Fig. 49 -

Summary